This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.


  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit May. 31, 2012

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Click Here to view the Journal of Managed Care Medicine

Online CME/CEU Programs
Multiple Myeloma: An Update on Diagnostic and Treatment Strategies

Advanced Treatment of Osteoporosis in Postmenopausal Women

Decreasing the Cost Burden of Fibromyalgia with Early Diagnosis and Management


Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!

Fall Managed Care Forum
November 8-9
Bellagio Hotel

 



 Genomics

Scientists hail largest release of childhood cancer genome data
Cancer Research U.K.    Share    Share on FacebookTwitterShare on LinkedinE-mail article
U.S. researchers have announced the largest release of childhood cancer genome data. Scientists at the Washington University Pediatric Cancer Genome Project announced in the journal Nature Genetics that they have released hundreds of genome sequences mapping the DNA of 260 children with cancer. More

What is the Health Economic Impact of a Non-Invasive Prenatal Test?

Learn About Bridgehead International’s report, authored by Susan Garfield, on the clinical and economic utility of this test in this quarter’s JMCM, entitled “Clinical and Cost Consequences of Incorporating a Novel Non-Invasive Prenatal Test into the Diagnostic Pathway for Fetal Trisomies.


Why genetic tests don't help doctors predict your disease risk
TIME    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Your DNA may hold valuable information about your health, but current genetic tests can't improve doctors' ability to predict your risk of major disease. More

Same gene that stunts infants' growth also makes them grow too big
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
UCLA geneticists have identified the mutation responsible for IMAGe* syndrome, a rare disorder that stunts infants' growth. The twist? The mutation occurs on the same gene that causes Beckwith-Wiedemann syndrome, which makes cells grow too fast, leading to very large children. More

 Biotech/Diagnostics/Personalized Medicine


Finnish scientists discover vaccine to eliminate allergies
Forbes    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In the United States, 65 million people have some type of allergy. In Europe, that number goes up to 87 million. Fifty-six percent are allergic to grasses in the United States versus 52 percent in Europe. Scientists discovered unique IgE‐binding structures in allergens. The team, through the formation of a new bio-tech company called Desentum, hope to have the vaccine on the market within five to seven years. More

Personalized treatment needed for blood pressure control
Laboratory Equipment    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Aggressive efforts to lower blood pressure in people with diabetes are paying off — perhaps too well, according to a new study. The research shows that there have been dramatic improvements in blood pressure control among patients with diabetes in the Department of Veterans Affairs, with as many as 82 percent of patients having blood pressure controlled and 94 percent getting appropriate BP treatment. More


Nursing@
Georgetown


Nursing@Georgetown is a Master’s in Nursing program delivered online by Georgetown University’s renowned School of Nursing & Health Studies.
MORE
Our activities touch many lives
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for cancer, cardiovascular, gastrointestinal and infection. MORE


 Regenerative Medicine


How nanotechnology is shaping stem cell research
The Guardian    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Nanoscientists have developed a technique that allows them to transform stem cells into bone cells on command. But could the process be used to treat deadly conditions such as heart disease and Parkinson's? More

Americans flocking to India for stem cell therapy
New York Daily News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A growing number of Americans are traveling to India to seek treatment for rare diseases through India's experimental embryonic stem cell therapy, according to an investigative report. Among them Cash Burnaman, a 6-year-old South Carolina boy, who traveled with his parents to India seeking treatment for a rare genetic condition that has left him developmentally disabled, CNN reported. More

 Emerging Medical Technologies


MIT builds a needle-free drug injector
NPR    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBriefThe needle and syringe are icons of modern medicine. But a device developed at MIT to squirt medicines quickly and pretty much painlessly through the skin suggests that the future of medicine could be needle-free. The idea is to shoot an extremely thin, extremely fast jet of medicine straight through skin and into muscle. More

Tattoos replace bracelets for medical alerts
MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
As more people with diabetes replace their medical alert bracelets with tattooed warnings, there might be a need for a standard design and body location, a researcher said. Medical alert tattoos for diabetes are a relatively new phenomenon. More

 Managed Healthcare News


Insurers making patients pay more for costly specialty drugs
Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Thousands of patients in California and across the nation who take expensive prescription drugs every month for cancer, rheumatoid arthritis and other ailments are facing sticker shock at the pharmacy. Increasingly, Anthem Blue Cross, Aetna and other insurers are shifting more prescriptions to a new category requiring patients to shoulder a larger share of the drug's cost. More

Most doctors headed for penalty over Medicare quality reporting
American Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Absent a significant change in the trajectory of Medicare's physician quality reporting system, a large majority of doctors will set themselves up for future rate cuts by failing to report enough quality measures to the federal government in 2013. A recent trends report from the Centers for Medicare & Medicaid Services shows fewer than 200,000 physicians, out of the more than 600,000 who were eligible for the incentive program, reported PQRS measures in 2010. More

 FDA: New Treatments and Technology


FDA turns down J&J's HIV pill
The Associated Press via Crain's New York Business    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Johnson & Johnson said the Food and Drug Administration has not approved its application to market a once-per-day version of its HIV pill Prezista and wants more information. The company said it is reviewing the FDA's response to its marketing application for an 800-milligram Prezista pill, and it plans to respond as quickly as possible. More

FDA warns J&J unit about tampon complaints
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
U.S. drug regulators chided a Johnson & Johnson unit for not reporting or investigating customer complaints about O.B. Tampons or personal lubricants similar to K-Y Jelly. The Food and Drug Administration said the unit, McNeil-PPC Inc, did not properly follow up on complaints that included toxic shock syndrome from using the tampon, according to a warning letter posted on the FDA's website. More

FAST FACTS
"Toxic shock syndrome is caused by a toxin produced by certain types of Staphylococcus bacteria, according to the National Institutes of Health. It can cause confusion, low blood pressure, muscle aches and vomiting."
 
Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
May 31, 2012
May 24, 2012
May 17, 2012
May 10, 2012



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063